KIF1B promotes glioma migration and invasion via cell surface localization of MT1-MMP.
In conclusion, targeting KIF1B may be an option for anti-invasive therapies targeting glioma.
PMID: 26576027 [PubMed - as supplied by publisher]
Source: Oncology Reports - Category: Cancer & Oncology Tags: Oncol Rep Source Type: research
More News: Brain Tumor | Cancer | Cancer & Oncology | Gastric (Stomach) Cancer | Gastroenterology | Glioma | Study